Population‐Based Differences inSchistosoma mansoni–and Hepatitis C–Induced Disease
Author(s) -
Ronald E. Blanton,
Ekram Abdel Salam,
H. Curtis Kariuki,
Philip Magak,
Luciano Kalabric Silva,
Eric M. Muchiri,
F. W. Thiongo,
Iman E. AbdelMeghid,
A Butterworth,
Mitermayer Galvão dos Reis,
John H. Ouma
Publication year - 2002
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/340574
Subject(s) - schistosoma mansoni , schistosomiasis , medicine , population , liver disease , hepatitis c , immunology , hepatitis , helminthiasis , disease , schistosoma , helminths , environmental health
Two populations with differing histories of Schistosoma mansoni and hepatitis C infection were compared directly for severity of disease and extent of comorbidity. Demographic, parasitologic, and ultrasound surveys were conducted on 2038 Egyptians and on 2120 Kenyans. Hepatitis B and C serologies and transaminase levels were obtained from a subset at each site. Despite significantly lower prevalence and intensity of infection, Egyptians had a higher prevalence of severe schistosomal fibrosis than Kenyans (36.8% vs. 4.6%). Hepatitis C infection was 3 times more prevalent among Egyptians, and evidence of hepatocellular damage was significantly greater among Egyptians. There was no interaction between S. mansoni infection or disease and the prevalence or severity of hepatitis C. For both infections, the intensity or prevalence of infection was a poor predictor of morbidity. The prevalence of disease in the Egyptian population from different pathogens suggests a generalized susceptibility to inflammatory liver disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom